Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Shares Repurchased: 2014-2022

Historic Shares Repurchased for Viking Therapeutics (VKTX) over the last 4 years, with Dec 2022 value amounting to $6.8 million.

  • Viking Therapeutics' Shares Repurchased was N/A to $1.7 million in Q2 2022 from the same period last year, while for Jun 2022 it was $6.8 million, marking a year-over-year change of. This contributed to the annual value of $6.8 million for FY2022, which is N/A change from last year.
  • According to the latest figures from FY2022, Viking Therapeutics' Shares Repurchased is $6.8 million, which was up 2,967,148.91% from $229 recorded in FY2016.
  • Over the past 5 years, Viking Therapeutics' Shares Repurchased peaked at $6.8 million during FY2022, and registered a low of $6.8 million during FY2022.
  • For the 1-year period, Viking Therapeutics' Shares Repurchased averaged around $6.8 million, with its median value being $6.8 million (2022).